title: Pharmacokinetic and pharmacodynamic study of suriclone imipramine interaction in man.
abstract: Suriclone is a novel cyclopyrrolone exhibiting anxiolytic activity. Twelve healthy Caucasian male volunteers participated in the study. A single dose of suriclone 0.4 mg, imipramine 75 mg, suriclone 0.4 mg + imipramine 75 mg, or placebo was given according to a 4 x 4 Latin-square design in order to assess the effect of drug association on pharmacokinetics and psychomotor performances. Visual analogue scale ratings, critical flicker frequency, choice visual reaction time, and Pauli, picture memory and Sternberg tests were performed before and 1.5, 6 and 9 h after drug administration. Suriclone, with the exception of the Pauli test, had no effect on psychomotor performances. The imipramine-suriclone association appeared to disturb some performances (no statistical significance), probably due to the effect of imipramine. Blood samples were collected for determination of imipramine and suriclone plasma levels respectively by high-performance liquid chromatography and radioimmunoassays. Suriclone AUC, Cmax and Tmax were not affected by imipramine, and reciprocally.
authors.affiliation: Service de Pharmacologie Clinique, CHU, Poitiers, France.
authors.forename: M C
authors.initials: MC
authors.lastname: Perault
authors.forename: G
authors.initials: G
authors.lastname: Chapelle
authors.forename: S
authors.initials: S
authors.lastname: Bouquet
authors.forename: P
authors.initials: P
authors.lastname: Chevalier
authors.forename: G
authors.initials: G
authors.lastname: Montay
authors.forename: J
authors.initials: J
authors.lastname: Gaillot
authors.forename: H
authors.initials: H
authors.lastname: Chakroun
authors.forename: P
authors.initials: P
authors.lastname: Guillet
authors.forename: B
authors.initials: B
authors.lastname: Vandel
mesh_terms: D000328:Adult; D014151:Anti-Anxiety Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D004311:Double-Blind Method; D004347:Drug Interactions; D005425:Flicker Fusion / Q000187:drug effects; D006801:Humans; D007099:Imipramine / Q000493:pharmacokinetics* / Q000494:pharmacology*; D008297:Male; D008568:Memory / Q000187:drug effects; D009287:Naphthyridines; D010879:Piperazines / Q000493:pharmacokinetics* / Q000494:pharmacology*; D011597:Psychomotor Performance / Q000187:drug effects*; D011863:Radioimmunoassay; D011930:Reaction Time / Q000187:drug effects; D013457:Sulfur Compounds
chemical_list: D014151:Anti-Anxiety Agents; D009287:Naphthyridines; D010879:Piperazines; D013457:Sulfur Compounds; C037283:suriclone; D007099:Imipramine